Protalix BioTherapeutics, Inc.

PLX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
8-K May 29, 2012 FORM 8-K
DEF 14A May 21, 2012
8-K May 10, 2012 FORM 8-K
PRE 14A May 9, 2012 PRELIMINARY PROXY STATEMENT
10-Q May 9, 2012 FORM 10-Q
4 May 4, 2012 OWNERSHIP DOCUMENT
4 May 4, 2012 OWNERSHIP DOCUMENT
4 May 4, 2012 OWNERSHIP DOCUMENT
4 May 4, 2012 OWNERSHIP DOCUMENT
8-K May 2, 2012 FORM 8-K
8-K Mar 19, 2012 FORM 8-K
10-K Feb 27, 2012
8-K Feb 23, 2012
424B5 Feb 16, 2012 424B5
8-K Feb 16, 2012 8-K
424B5 Feb 15, 2012 424B5
8-K Feb 15, 2012 8-K
SC 13G/A Feb 10, 2012
SC 13G Feb 9, 2012
8-K Feb 9, 2012 FORM 8-K
CT ORDER Feb 1, 2012
8-K Jan 26, 2012
SC 13G/A Jan 17, 2012
8-K Dec 13, 2011
8-K Dec 6, 2011 FORM 8-K
← Newer Page 24 of 38 · 935 filings Older →